Keller v. Kijakazi

CourtDistrict Court, S.D. California
DecidedSeptember 19, 2023
Docket3:22-cv-00707
StatusUnknown

This text of Keller v. Kijakazi (Keller v. Kijakazi) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Keller v. Kijakazi, (S.D. Cal. 2023).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 MATTHEW KELLER, Case No.: 3:22-CV-707-WVG

12 Plaintiff, ORDER ON JOINT MOTION FOR 13 v. JUDICIAL REVIEW 14 KILOLO KIJAKAZI, Acting Commissioner of the Social Security 15 Administration, 16 Defendant. 17 18 19 I. INTRODUCTION 20 This action arises from the Commissioner of Social Security’s (“Commissioner” or 21 Defendant”) denial of Matthew Keller’s (“Plaintiff”) application for Supplemental Security 22 Income (“SSI”) benefits under Title XVI of the Social Security Act (“Title XVI” or the 23 “Act”). (Doc. No. 1.) On February 28, 2023, the Parties filed a Joint Motion for Judicial 24 Review of the Final Decision of the Commissioner of Social Security (“Joint Motion”) 25 pursuant to the Court’s October 27, 2022 Scheduling Order. (Doc. No. 16.) The Joint 26 Motion addresses four issues: whether Administrative Law Judge (“ALJ”) Charles Woode 27 (“ALJ Woode”) erred in (1) analyzing the paragraph C criteria of the Act’s Listings 12.03 28 and 12.04; (2) assessing the medical opinions of Dr. Bohn and Dr. Giglio; (3) formulating 1 Plaintiff’s residual functional capacity (“RFC”); and (4) evaluating Plaintiff’s 2 noncompliance with medication. See Doc. No. 16. Having reviewed and considered the 3 Parties’ submissions, the Court DENIES Plaintiff’s Motion for Summary Judgment and 4 GRANTS Defendant’s Motion for Summary Judgment. 5 II. PROCEDURAL HISTORY 6 On July 25, 2019, Plaintiff applied for SSI benefits under Title XVI. (AR 312-18.) 7 Plaintiff’s application was twice denied, initially on September 6, 2019, and upon 8 reconsideration on March 23, 2020. (AR 131-35; 146-50.) On April 23, 2020, ALJ Woode 9 received Plaintiff’s written request for a hearing. (AR 151-54.) On December 3, 2020, 10 Plaintiff telephonically appeared before ALJ Woode and requested legal representation, 11 which ALJ Woode granted. (AR 37-45). On April 19, 2021, Plaintiff appeared and 12 testified at the telephonic administrative hearing, pursuant to his agreement to appear 13 telephonically. (AR 46-72, 245, 289-93.) 14 On May 10, 2021, ALJ Woode convened a supplemental hearing to obtain the 15 testimony of impartial vocational expert Esperanza DiStefano. (AR 15, 73-83.) Plaintiff 16 and Plaintiff’s counsel attended this hearing telephonically. (Id.) 17 On May 19, 2021, ALJ Woode issued an unfavorable decision on Plaintiff’s 18 Application for SSI benefits. (AR 12-28.) On April 27, 2022, the Appeals Council denied 19 Plaintiff’s Request for Review, finalizing ALJ Woode’s decision on Plaintiff’s application 20 for benefits. (AR 1-6.) On May 17, 2022, Plaintiff filed this instant action seeking judicial 21 review of ALJ Woode’s Decision. (Doc. No. 1.) 22 III. FACTUAL BACKGROUND 23 a. Plaintiff’s Medical History and Allegations 24 Plaintiff is twenty-two years old and alleges he is unable to work due to mental 25 impairments. (AR 247-48; 305; 561.) Plaintiff alleges a disability onset date of January 26 7, 2019. (AR 312-18.) Plaintiff has a high school education and no past relevant work. 27 (AR 27.) In addition to Plaintiff’s alleged mental impairments, Plaintiff has a mild 28 intellectual disability and fetal alcohol syndrome. (AR 343-51; 488-89, 491; 662; 727-30; 1 734-36, 741.) With respect to Plaintiff’s mental impairments, Plaintiff contends he suffers 2 from schizoaffective disorder (depressive type), paranoia, delusions, psychosis, major 3 depressive disorder, intellectual disability, memory issues, headaches, and intramuscular 4 disorder causing collapse. (AR 483.) Plaintiff’s medical records reflect a history of 5 suicidal ideations and attempted suicides. (AR 347; 488-89, AR 491; 589.) 6 b. Early Treatment and Diagnosis 7 January 2019 was the first time Plaintiff received medical attention for his mental 8 impairments. (AR 491; 583; 658.) Between January 2019 and June 2019, Plaintiff was 9 brought to the emergency department three times for psychiatric evaluation under 10 California Welfare and Institutions Code Section 5150 (“5150 hold”) due to command 11 auditory hallucinations, which directed Plaintiff to engage in self-harm and suicidal acts, 12 and stress associated with his home and work life. (AR 488-91; 570-72; 583-86.) Plaintiff 13 also reported struggling with sleep. (AR 251; 334, 341-42, 348, 350-51; 380, 399.) During 14 each discharge, Plaintiff seemed willing to engage in daily living tasks and comply with 15 his treatment regime and had decreased thoughts about suicide and self-harm. (AR 508; 16 571-72, 598-99.) 17 On January 7, 2019, Plaintiff was admitted to Aurora Behavioral Health Care under 18 a 5150 hold. (AR 570-78, 583-593.) Ryan Wilke, D.O., (“Dr. Wilke”) treated Plaintiff 19 during his admittance at Aurora Behavioral Health Care. (Id.) Plaintiff reported he told his 20 parents he was depressed but “they don’t listen”. (AR 583.) Plaintiff reported he was not 21 taking any medications at admittance and during the course of treatment, with adjustments 22 to Lexapro and Seroquel, one-on-one psychotherapy sessions, escalation of privileges and 23 responsibilities (allowed to go to the gym, alone time at staff discretion and to the cafeteria 24 for meals), and family counseling sessions, “his depression improved and suicidality 25 completed resolved.” (AR 854.) At discharge, Plaintiff was future-oriented with improved 26 mood and insight, consistently denied passive or active suicidal or violent ideations, and 27 was noted to be capable of understanding the risk of nonadherence to his medications 28 prescribed. (Id.) 1 On May 29, 2019, Plaintiff presented before Dr. Wilke with suicidal ideations and 2 “auditory hallucinations telling him to kill himself” and reported his job at a waterpark was 3 “too stressful”. (AR 570, 573, 575.) However, Dr. Wilke noted Plaintiff “contract[ed] for 4 safety in the hospital” and displayed calm and cooperative behaviors regarding his 5 medication and intensive treatment programs while he was admitted. (AR 571-72, 575- 6 76.) Plaintiff contended his outpatient program was “not working.” (AR 570, 575.) 7 Plaintiff contended he did not feel Lexapro and Risperdal were helping him. (AR 658.) 8 Upon discharge on June 3, 2019, Plaintiff seemed “stabilized and improving” and “denie[d] 9 any intent to harm himself . . . in treatment at the hospital and denie[d] any passive or active 10 homicidal or violent ideation, intent, or plan.” (AR 570-71.) At discharge, Dr. Wilke noted 11 Plaintiff was denying any passive or active suicidal, homicidal or violent ideations, and 12 demonstrated agreeableness regarding active engagement in those treatment plans 13 addressing his “acute symptomology causing complete functional impairment.” (AR 570- 14 71.) 15 c. Dr. Bohn’s Assessment of Plaintiff 16 On June 25, 2019, and June 27, 2019, Sara A. Bohn, Ph.D. (“Dr. Bohn”) conducted 17 neuropsychological assessments of Plaintiff. (AR 658-662.) Dr. Bohn conducted a clinical 18 interview, the Wechsler Adult Intelligence Scale – Fourth Edition (WAIS-IV) Test, the 19 Wechsler Memory Scale – Fourth Edition (WMS-IV), the Conners Continuous 20 Performance Test – Third Edition (CPT-3), the Woodcock-Johnson Tests of Achievement 21 IV, the Wisconsin Card Sort Test, and the Personality Assessment Inventory (PAI). (AR 22 660.) 23 Plaintiff’s performance on the WAIS-IV placed him in the “low average to 24 borderline ranges of cognitive skill.” (AR 660; 673.) Additionally, Plaintiff performed in 25 the “low average to extremely low ranges of memory functioning when compared to same 26 aged peers” on the WMS-IV. (AR 660-61.) Dr. Bohn determined the WMS-IV revealed 27 Plaintiff “will struggle with most aspects of memory.” (AR 661.) The CPT-3 test showed 28 that Plaintiff would have a “moderate likelihood of having a formal attention deficit 1 disorder” and likely struggle with inattention and problem-solving even with help from 2 others.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. De Los Santos
420 F.3d 10 (First Circuit, 2005)
Vincent v. Heckler
739 F.2d 1393 (Ninth Circuit, 1984)
Thomas Andrade v. Commissioner of Social Securit
474 F. App'x 642 (Ninth Circuit, 2012)
Tommasetti v. Astrue
533 F.3d 1035 (Ninth Circuit, 2008)
Richard Kennedy v. Carolyn W. Colvin
738 F.3d 1172 (Ninth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Keller v. Kijakazi, Counsel Stack Legal Research, https://law.counselstack.com/opinion/keller-v-kijakazi-casd-2023.